1. Gilson, Pauline, Drouot, Guillaume, Witz, Andréa, Becuwe, Philippe, Harlé, Alexandre. 2019. Emerging Roles of DDB2 in Cancer. In International journal of molecular sciences, 20, . doi:10.3390/ijms20205168. https://pubmed.ncbi.nlm.nih.gov/31635251/
2. Itoh, Toshiki, Cado, Dragana, Kamide, Ryoichi, Linn, Stuart. 2004. DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen. In Proceedings of the National Academy of Sciences of the United States of America, 101, 2052-7. doi:. https://pubmed.ncbi.nlm.nih.gov/14769931/
3. Dardare, Julie, Witz, Andréa, Betz, Margaux, Harlé, Alexandre, Gilson, Pauline. 2022. DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy. In Frontiers in oncology, 12, 1052163. doi:10.3389/fonc.2022.1052163. https://pubmed.ncbi.nlm.nih.gov/36568213/
4. Wu, Xiaojun, Yu, Min, Zhang, Zhuxia, Xie, Ni, Lu, Fei. 2021. DDB2 regulates DNA replication through PCNA-independent degradation of CDT2. In Cell & bioscience, 11, 34. doi:10.1186/s13578-021-00540-5. https://pubmed.ncbi.nlm.nih.gov/33557942/
5. Bommi, Prashant V, Ravindran, Sriram, Raychaudhuri, Pradip, Bagchi, Srilata. 2018. DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma. In Oncotarget, 9, 34708-34718. doi:10.18632/oncotarget.26168. https://pubmed.ncbi.nlm.nih.gov/30410671/
6. Bommi, Prashant V, Chand, Vaibhav, Mukhopadhyay, Nishit K, Raychaudhuri, Pradip, Bagchi, Srilata. 2019. NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC. In Oncogene, 39, 1784-1796. doi:10.1038/s41388-019-1105-y. https://pubmed.ncbi.nlm.nih.gov/31740787/
7. Cui, Tiantian, Srivastava, Amit Kumar, Han, Chunhua, Wani, Altaf A, Wang, Qi-En. 2018. DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1. In Cell death & disease, 9, 561. doi:10.1038/s41419-018-0585-y. https://pubmed.ncbi.nlm.nih.gov/29752431/